In order to keep our views proprietary and maximize time spent on investing, I am relinquishing authorship of our Quarterly Letter, which will now focus on analysis of portfolio positions, and business developments. I will share my market observations and outlook on our Investor Quarterly Calls. In addition, I may send out investment memos on an ad-hoc basis should it be in the interest of our investors.
$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now
The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)